The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Public ClinicalTrials.gov record NCT00303303. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00303303
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Enrollment
- 13 participants
Conditions and interventions
Conditions
Interventions
- Crotaline Immune Fab (ovine) (active initial therapy; placebo maintenance therapy) Biological
- Crotaline Polyvalent Immune Fab (ovine) (active initial and maintenance therapy) Biological
- Placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 12 Months and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2005
- Primary completion
- Apr 30, 2008
- Completion
- Apr 30, 2008
- Last update posted
- Nov 30, 2023
2005 – 2008
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Carolinas Medical Center | Charlotte | North Carolina | 28232 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Richland Memorial Hospital | Columbia | South Carolina | 29203 | — |
| Medical College of Virigina/Virginia Commonwealth University Hospital | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00303303, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 30, 2023 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00303303 live on ClinicalTrials.gov.